Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

[Genetic diagnosis of the endometrial cancer].

Kimura T, Fujita M, Kobayashi E, Ueda Y, Yoshino K, Enomoto T.

Nihon Rinsho. 2012 Jun;70 Suppl 4:367-71. Japanese. No abstract available.

PMID:
23156272
[PubMed - indexed for MEDLINE]
2.

[Topics on gene abnormality in endometrial cancer].

Shiozawa T, Konishi I.

Nihon Rinsho. 2004 Oct;62 Suppl 10:259-63. Review. Japanese. No abstract available.

PMID:
15535247
[PubMed - indexed for MEDLINE]
3.

[Genetic abnormalities in the pathogenesis of ovarian cancer].

Yoshino K, Ueda Y, Kimura T, Kobayashi E, Fujita M, Enomoto T.

Nihon Rinsho. 2012 Jun;70 Suppl 4:480-7. Japanese. No abstract available.

PMID:
23156294
[PubMed - indexed for MEDLINE]
4.

[Molecular mechanisms in endometrial carcinoma].

Nakao Y, Iwasaka T.

Nihon Rinsho. 2004 Oct;62 Suppl 10:248-53. Review. Japanese. No abstract available.

PMID:
15535245
[PubMed - indexed for MEDLINE]
5.

Novel molecular profiles of endometrial cancer-new light through old windows.

Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colás E, Llauradó M, Alazzouzi H, Planagumá J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Reventós J.

J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):221-9. Epub 2007 Sep 15. Review.

PMID:
18061438
[PubMed - indexed for MEDLINE]
6.

Molecular genetics and endometrial cancer.

Lalloo F, Evans G.

Best Pract Res Clin Obstet Gynaecol. 2001 Jun;15(3):355-63. Review.

PMID:
11476558
[PubMed - indexed for MEDLINE]
7.

Advances in the molecular genetics of endometrial cancer (Review).

Esteller M, Xercavins J, Reventos J.

Oncol Rep. 1999 Nov-Dec;6(6):1377-82. Review.

PMID:
10523715
[PubMed - indexed for MEDLINE]
8.

Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.

Peterson LM, Kipp BR, Halling KC, Kerr SE, Smith DI, Distad TJ, Clayton AC, Medeiros F.

Int J Gynecol Pathol. 2012 May;31(3):195-205. doi: 10.1097/PGP.0b013e318231fc51.

PMID:
22498935
[PubMed - indexed for MEDLINE]
9.

Molecular genetic characterization of tamoxifen-associated endometrial cancer.

Prasad M, Wang H, Douglas W, Barakat RR, Ellenson LH.

Gynecol Oncol. 2005 Jan;96(1):25-31.

PMID:
15589576
[PubMed - indexed for MEDLINE]
10.

Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.

Yasue A, Hasegawa K, Udagawa Y.

Hum Cell. 2011 Jun;24(2):65-73. doi: 10.1007/s13577-010-0005-9. Epub 2011 Jan 22.

PMID:
21547354
[PubMed - indexed for MEDLINE]
11.

Molecular pathology of endometrial hyperplasia and carcinoma.

Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Muñoz J, Argüelles R, Machin P, Prat J.

Hum Pathol. 2001 Jun;32(6):569-77. Review.

PMID:
11431710
[PubMed - indexed for MEDLINE]
12.

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

Nout RA, Bosse T, Creutzberg CL, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, van Eijk R, Ter Haar NT, Smit VT.

Gynecol Oncol. 2012 Sep;126(3):466-73. doi: 10.1016/j.ygyno.2012.05.012. Epub 2012 May 15.

PMID:
22609107
[PubMed - indexed for MEDLINE]
13.

[Genetic abnormalities in endometrial cancer].

Takeshima N, Hirai Y.

Nihon Rinsho. 2004 Oct;62 Suppl 10:254-8. Review. Japanese. No abstract available.

PMID:
15535246
[PubMed - indexed for MEDLINE]
14.

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

Velasco A, Bussaglia E, Pallares J, Dolcet X, Llobet D, Encinas M, Llecha N, Palacios J, Prat J, Matias-Guiu X.

Hum Pathol. 2006 Nov;37(11):1465-72. Epub 2006 Jul 26.

PMID:
16949921
[PubMed - indexed for MEDLINE]
15.

[Genetic diagnosis of endometrial cancer].

Kanaya T, Kyo S, Maida Y, Inoue M.

Nihon Rinsho. 2004 Oct;62 Suppl 10:295-8. Review. Japanese. No abstract available.

PMID:
15535254
[PubMed - indexed for MEDLINE]
16.

Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations.

Konopka B, Janiec-Jankowska A, Czapczak D, Paszko Z, Bidziński M, Olszewski W, Goluda C.

J Cancer Res Clin Oncol. 2007 Jun;133(6):361-71. Epub 2007 Jan 12.

PMID:
17219201
[PubMed - indexed for MEDLINE]
17.

Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.

Koul A, Willén R, Bendahl PO, Nilbert M, Borg A.

Cancer. 2002 May 1;94(9):2369-79.

PMID:
12015762
[PubMed - indexed for MEDLINE]
Free Article
18.

Microsatellite instability and somatic mutations in endometrial carcinomas.

Sakamoto T, Murase T, Urushibata H, Kato K, Takada H, Imamura T, Mori H, Wake N.

Gynecol Oncol. 1998 Oct;71(1):53-8.

PMID:
9784319
[PubMed - indexed for MEDLINE]
19.

Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.

Ioffe OB, Papadimitriou JC, Drachenberg CB.

Hum Pathol. 1998 Oct;29(10):1150-9.

PMID:
9781657
[PubMed - indexed for MEDLINE]
20.

Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway.

Murayama-Hosokawa S, Oda K, Nakagawa S, Ishikawa S, Yamamoto S, Shoji K, Ikeda Y, Uehara Y, Fukayama M, McCormick F, Yano T, Taketani Y, Aburatani H.

Oncogene. 2010 Apr 1;29(13):1897-908. doi: 10.1038/onc.2009.474. Epub 2010 Jan 11.

PMID:
20062086
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk